Works matching AU Dueck, Amylou C.

Results: 112
    1

    North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.

    Published in:
    2012
    By:
    • Sideras K;
    • Dueck AC;
    • Hobday TJ;
    • Rowland KM Jr;
    • Allred JB;
    • Northfelt DW;
    • Lingle WL;
    • Behrens RJ;
    • Fitch TR;
    • Nikcevich DA;
    • Perez EA;
    • Sideras, Kostandinos;
    • Dueck, Amylou C;
    • Hobday, Timothy J;
    • Rowland, Kendrith M Jr;
    • Allred, Jacob B;
    • Northfelt, Donald W;
    • Lingle, Wilma L;
    • Behrens, Robert J;
    • Fitch, Tom R
    Publication type:
    journal article
    2
    3

    Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.

    Published in:
    BMC Medical Genomics, 2010, v. 3, p. 60, doi. 10.1186/1755-8794-3-60
    By:
    • Reinholz, Monica M.;
    • Eckel-Passow, Jeanette E.;
    • Anderson, S. Keith;
    • Asmann, Yan W.;
    • Zschunke, Michael A.;
    • Oberg, Ann L.;
    • McCullough, Ann E.;
    • Dueck, Amylou C.;
    • Beiyun Chen;
    • April, Craig S.;
    • Wickham-Garcia, Eliza;
    • Jenkins, Robert B.;
    • Cunningham, Julie M.;
    • Jin Jen;
    • Perez, Edith A.;
    • Jian-Bing Fan;
    • Lingle, Wilma L.
    Publication type:
    Article
    4
    5

    Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

    Published in:
    2010
    By:
    • Kearns AE;
    • Northfelt DW;
    • Dueck AC;
    • Atherton PJ;
    • Dakhil SR;
    • Rowland KM Jr;
    • Fuloria J;
    • Flynn PJ;
    • Dentchev T;
    • Loprinzi CL;
    • Kearns, Ann E;
    • Northfelt, Donald W;
    • Dueck, Amylou C;
    • Atherton, Pamela J;
    • Dakhil, Shaker R;
    • Rowland, Kendrith M Jr;
    • Fuloria, Jyotsna;
    • Flynn, Patrick J;
    • Dentchev, Todor;
    • Loprinzi, Charles L
    Publication type:
    journal article
    6

    The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.

    Published in:
    2009
    By:
    • Sprangers, Mirjam A. G.;
    • Sloan, Jeff A.;
    • Veenhoven, Ruut;
    • Cleeland, Charles S.;
    • Halyard, Michele Y.;
    • Abertnethy, Amy P.;
    • Baas, Frank;
    • Barsevick, Andrea M.;
    • Bartels, Meike;
    • Boomsma, Dorret I.;
    • Chauhan, Cynthia;
    • Dueck, Amylou C.;
    • Frost, Marlene H.;
    • Hall, Per;
    • Klepstad, Pål;
    • Martin, Nicholas G.;
    • Miaskowski, Christine;
    • Mosing, Miriam;
    • Movsas, Benjamin;
    • Van Noorden, Cornelis J. F.
    Publication type:
    journal article
    7
    8
    9

    The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.

    Published in:
    2016
    By:
    • Geyer, Holly L.;
    • Andreasson, Bjorn;
    • Kosiorek, Heidi E.;
    • Dueck, Amylou C.;
    • Scherber, Robyn M.;
    • Martin, Kari A.;
    • Butler, Kristina A.;
    • Harrison, Claire N.;
    • Radia, Deepti H.;
    • Cervantes, Francisco;
    • Kiladjian, Jean‐Jacques;
    • Reiter, Andreas;
    • Birgegard, Gunnar;
    • Passamonti, Francesco;
    • Senyak, Zhenya;
    • Vannucchi, Alessandro M.;
    • Paoli, Chiara;
    • Xiao, Zhijian;
    • Samuelsson, Jan;
    • Mesa, Ruben A.
    Publication type:
    journal article
    10
    11

    Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 15, p. 2675, doi. 10.1002/cncr.28130
    By:
    • Moreno‐Aspitia, Alvaro;
    • Hillman, David W.;
    • Dyar, Stephen H.;
    • Tenner, Kathleen S.;
    • Gralow, Julie;
    • Kaufman, Peter A.;
    • Davidson, Nancy E.;
    • Lafky, Jacqueline M.;
    • Reinholz, Monica M.;
    • Lingle, Wilma L.;
    • Kutteh, Leila A.;
    • Carney, Walter P.;
    • Dueck, Amylou C.;
    • Perez, Edith A.
    Publication type:
    Article
    12
    13
    14

    Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 6, p. 1065, doi. 10.1111/bjh.18329
    By:
    • Kosiorek, Heidi E.;
    • Scherber, Robyn M.;
    • Geyer, Holly L.;
    • Verstovsek, Srdan;
    • Langlais, Blake T.;
    • Mazza, Gina L.;
    • Gotlib, Jason;
    • Gupta, Vikas;
    • Padrnos, Leslie J.;
    • Palmer, Jeanne M.;
    • Fleischman, Angela;
    • Mesa, Ruben A.;
    • Dueck, Amylou C.
    Publication type:
    Article
    15
    16
    17
    18

    Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

    Published in:
    2016
    By:
    • Sonnenblick, Amir;
    • de Azambuja, Evandro;
    • Agbor-tarh, Dominique;
    • Bradbury, Ian;
    • Campbell, Christine;
    • Yingjie Huang;
    • Dueck, Amylou C.;
    • Pritchard, Kathleen I.;
    • Wolff, Antonio C.;
    • Jackisch, Christian;
    • Lang, Istvan;
    • Untch, Michael;
    • Smith, Ian;
    • Boyle, Frances;
    • Binghe Xu;
    • Gomez, Henry;
    • Perez, Edith A.;
    • Piccart, Martine;
    • Azim Jr., Hatem A.;
    • Huang, Yingjie
    Publication type:
    journal article
    19

    Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

    Published in:
    2014
    By:
    • Basch, Ethan;
    • Reeve, Bryce B;
    • Mitchell, Sandra A;
    • Clauser, Steven B;
    • Minasian, Lori M;
    • Dueck, Amylou C;
    • Mendoza, Tito R;
    • Hay, Jennifer;
    • Atkinson, Thomas M;
    • Abernethy, Amy P;
    • Bruner, Deborah W;
    • Cleeland, Charles S;
    • Sloan, Jeff A;
    • Chilukuri, Ram;
    • Baumgartner, Paul;
    • Denicoff, Andrea;
    • St Germain, Diane;
    • O'Mara, Ann M;
    • Chen, Alice;
    • Kelaghan, Joseph
    Publication type:
    journal article
    20

    Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju244
    By:
    • Basch, Ethan;
    • Reeve, Bryce B.;
    • Mitchell, Sandra A.;
    • Clauser, Steven B.;
    • Minasian, Lori M.;
    • Dueck, Amylou C.;
    • Mendoza, Tito R.;
    • Hay, Jennifer;
    • Atkinson, Thomas M.;
    • Abernethy, Amy P.;
    • Bruner, Deborah W.;
    • Cleeland, Charles S.;
    • Sloan, Jeff A.;
    • Chilukuri, Ram;
    • Baumgartner, Paul;
    • Denicoff, Andrea;
    • St. Germain, Diane;
    • O’Mara, Ann M.;
    • Chen, Alice;
    • Kelaghan, Joseph
    Publication type:
    Article
    21

    Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju129
    By:
    • Reeve, Bryce B.;
    • Mitchell, Sandra A.;
    • Dueck, Amylou C.;
    • Basch, Ethan;
    • Celia, David;
    • Miller Reilly, Carolyn;
    • Minasian, Lori M.;
    • Denicoff, Andrea M.;
    • O'Mara, Ann M.;
    • Fisch, Michael J.;
    • Chauhan, Cynthia;
    • Aaronson, Neil K.;
    • Coens, Corneel;
    • Watkins Bruner, Deborah
    Publication type:
    Article
    22

    Response.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 958, doi. 10.1093/jnci/djs244
    By:
    • Perez, Edith A.;
    • Dueck, Amylou C.
    Publication type:
    Article
    23
    24

    Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    2019
    By:
    • Chung, Arlene E;
    • Shoenbill, Kimberly;
    • Mitchell, Sandra A;
    • Dueck, Amylou C;
    • Schrag, Deborah;
    • Bruner, Deborah W;
    • Minasian, Lori M;
    • Germain, Diane St.;
    • O'Mara, Ann M;
    • Baumgartner, Paul;
    • Rogak, Lauren J;
    • Abernethy, Amy P;
    • Griffin, Ashley C;
    • Basch, Ethan M;
    • St Germain, Diane
    Publication type:
    journal article
    25
    26

    TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
    By:
    • Cook, Joselle;
    • Kah-Whye Peng;
    • Geyer, Susan;
    • Dueck, Amylou C.;
    • Ginos, Brenda F.;
    • Giers, Marissa;
    • Packiriswamy, Nandakumar;
    • Lianwen Zhang;
    • Brunton, Beth;
    • Patnaik, Mrnal S.;
    • Witzig, Thomas;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Gertz, Morie;
    • Go, Ronald;
    • Hayman, Suzanne;
    • Lust, John;
    • Dingli, David;
    • Rajkumar, S Vincent;
    • Leung, Nelson
    Publication type:
    Article
    27

    Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01560-3
    By:
    • Cook, Joselle;
    • Peng, Kah-Whye;
    • Geyer, Susan;
    • C. Dueck, Amylou;
    • F. Ginos, Brenda;
    • Giers, Marissa;
    • Packiriswamy, Nandakumar;
    • Zhang, Lianwen;
    • Brunton, Beth;
    • S. Patnaik, Mrnal;
    • Witzig, Thomas;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Gertz, Morie;
    • Go, Ronald;
    • Hayman, Suzanne;
    • Lust, John;
    • Dingli, David;
    • Vincent Rajkumar, S;
    • Leung, Nelson
    Publication type:
    Article
    28

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    29
    30
    31
    32
    33
    34
    35

    Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z
    By:
    • Reni, Michele;
    • Braverman, Julia;
    • Hendifar, Andrew;
    • Li, Chung-Pin;
    • Macarulla, Teresa;
    • Oh, Do-Youn;
    • Riess, Hanno;
    • Tempero, Margaret;
    • Lu, Brian;
    • Marcus, James;
    • Joshi, Namita;
    • Botteman, Marc;
    • Dueck, Amylou C.
    Publication type:
    Article
    36

    Microsatellitosis in Patients with Melanoma.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 1, p. 33, doi. 10.1245/s10434-018-7006-4
    By:
    • Karakousis, Giorgos C.;
    • Gimotty, Phyllis A.;
    • Leong, Stanley P.;
    • Pockaj, Barbara A.;
    • White, Richard L.;
    • O'Donoghue, Cristina;
    • Sinnamon, Andrew J.;
    • Bartlett, Edmund K.;
    • Dueck, Amylou C.;
    • Gould Rothberg, Bonnie E.;
    • Messina, Jane L.;
    • Vetto, John T.;
    • Sondak, Vernon K.;
    • Schneebaum, Schlomo;
    • Kashani-Sabet, Mohammed;
    • Han, Dale;
    • Faries, Mark B.;
    • Zager, Jonathan S.;
    • with the Sentinel Lymph Node Working Group
    Publication type:
    Article
    37
    38

    Fibrillar amyloid correlates of preclinical cognitive decline.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 1, p. e1, doi. 10.1016/j.jalz.2013.01.009
    By:
    • Stonnington, Cynthia M.;
    • Chen, Kewei;
    • Lee, Wendy;
    • Locke, Dona E.C.;
    • Dueck, Amylou C.;
    • Liu, Xiaofen;
    • Roontiva, Auttawut;
    • Fleisher, Adam S.;
    • Caselli, Richard J.;
    • Reiman, Eric M.
    Publication type:
    Article
    39

    The neuropsychology of normal aging and preclinical Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 1, p. 84, doi. 10.1016/j.jalz.2013.01.004
    By:
    • Caselli, Richard J.;
    • Locke, Dona E.C.;
    • Dueck, Amylou C.;
    • Knopman, David S.;
    • Woodruff, Bryan K.;
    • Hoffman-Snyder, Charlene;
    • Rademakers, Rosa;
    • Fleisher, Adam S.;
    • Reiman, Eric M.
    Publication type:
    Article
    40

    Longitudinal modeling of cognitive aging and the TOMM40 effect

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 6, p. 490, doi. 10.1016/j.jalz.2011.11.006
    By:
    • Caselli, Richard J.;
    • Dueck, Amylou C.;
    • Huentelman, Matthew J.;
    • Lutz, Michael W.;
    • Saunders, Ann M.;
    • Reiman, Eric M.;
    • Roses, Allen D.
    Publication type:
    Article
    41

    Sample size estimates for pre-symptomatic Alzheimer's disease treatment/surrogate marker development trials in Apolipoprotein E4 homozygotes close to their estimated age at symptomatic onset

    Published in:
    2010
    By:
    • Reiman, Eric M.;
    • Chen, Kewei;
    • Dueck, Amylou C.;
    • Fleisher, Adam S.;
    • Langbaum, Jessica B.;
    • Ayutyanont, Napatkamon;
    • Reschke, Cole;
    • Liu, Xiaofen;
    • Bandy, Dan;
    • Reeder, Stephanie A.;
    • Henslin, Bruce R.;
    • Yee-Benedetto, Sandra C.H.;
    • Tariot, Piere N.;
    • Keppler, Jennifer;
    • Alexander, Gene E.;
    • Caselli, Richard J.
    Publication type:
    Abstract
    42
    43

    Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

    Published in:
    2016
    By:
    • Bennett, Antonia V.;
    • Dueck, Amylou C.;
    • Mitchell, Sandra A.;
    • Mendoza, Tito R.;
    • Reeve, Bryce B.;
    • Atkinson, Thomas M.;
    • Castro, Kathleen M.;
    • Denicoff, Andrea;
    • Rogak, Lauren J.;
    • Harness, Jay K.;
    • Bearden, James D.;
    • Bryant, Donna;
    • Siegel, Robert D.;
    • Schrag, Deborah;
    • Basch, Ethan;
    • National Cancer Institute PRO-CTCAE Study Group
    Publication type:
    journal article
    44
    45

    Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

    Published in:
    Journal of Rheumatology, 2019, v. 46, n. 8, p. 1053, doi. 10.3899/jrheum.181123
    By:
    • Andersen, Kathleen M.;
    • Cheah, Jonathan T. L.;
    • March, Lyn;
    • Bartlett, Susan J.;
    • Beaton, Dorcas;
    • Bingham III, Clifton O.;
    • Brooks, Peter M.;
    • Christensen, Robin;
    • Conaghan, Philip G.;
    • D'Agostino, Maria-Antonietta;
    • de Wit, Maarten;
    • Dueck, Amylou C.;
    • Goodman, Susan M.;
    • Grosskleg, Shawna;
    • Hill, Catherine L.;
    • Howell, Martin;
    • Mackie, Sarah L.;
    • Richards, Bethan;
    • Shea, Beverly;
    • Singh, Jasvinder A.
    Publication type:
    Article
    46
    47
    48

    Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD).

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 6, p. 1242, doi. 10.1002/cncr.34062
    By:
    • Tilburt, Jon C.;
    • Zahrieh, David;
    • Pacyna, Joel E.;
    • Petereit, Daniel G.;
    • Kaur, Judith S.;
    • Rapkin, Bruce D.;
    • Grubb, Robert L.;
    • Chang, George J.;
    • Morris, Michael J.;
    • Kovac, Evan Z.;
    • Babaian, Kara N.;
    • Sloan, Jeff A.;
    • Basch, Ethan M.;
    • Peil, Elizabeth S.;
    • Dueck, Amylou C.;
    • Novotny, Paul J.;
    • Paskett, Electra D.;
    • Buckner, Jan C.;
    • Joyce, Daniel D.;
    • Montori, Victor M.
    Publication type:
    Article
    49
    50